Pediatricians published their own vaccine schedule, and it no longer matches CDC's

For most of the past three decades the United States had one childhood immunization schedule. The federal government published it, the major pediatric and family medicine organisations endorsed it, and the endorsement was the point: a single document that a clinician, an insurer, a school nurse, and a parent could all read the same way.

On January 26 the American Academy of Pediatrics published its 2026 childhood and adolescent immunization schedule, and the single document became two [s1].

What the AAP schedule says

The AAP schedule continues to recommend routine vaccines protecting children against 18 preventable diseases, among them respiratory syncytial virus, hepatitis A, hepatitis B, rotavirus, influenza, and meningococcal disease [s1]. The Academy describes the recommendations as remaining largely unchanged from its prior guidance released in August 2025 [s1].

Twelve medical and health care organisations have endorsed the schedule: the American Academy of Family Physicians, the American College of Nurse-Midwives, the American College of Obstetricians and Gynecologists, the American Medical Association, the American Pharmacists Association, the Council of Medical Specialty Societies, the Infectious Diseases Society of America, the National Association of Pediatric Nurse Practitioners, the National Medical Association, the Pediatric Infectious Diseases Society, the Pediatric Pharmacy Association, and the Society for Adolescent Health and Medicine [s1].

"Routine childhood immunizations are an important early step in the path to lifelong health," AAP President Andrew Racine said [s1]. Sean O'Leary, who chairs the Academy's Committee on Infectious Diseases, described the reasoning behind the timing of doses: "The pacing and combination of vaccines are based on what we know about when your child's immune system is ready to learn and respond best" [s1].

Where it diverges

The federal schedule was rewritten three weeks earlier. On January 5, Deputy HHS Secretary Jim O'Neill, acting as CDC Director, signed a decision memorandum restructuring the schedule into three categories: vaccines recommended for all children, vaccines recommended for certain high-risk groups, and vaccines subject to shared clinical decision-making [s2].

The first category contains 11 vaccines — for measles, mumps, rubella, polio, pertussis, tetanus, diphtheria, Haemophilus influenzae type b, pneumococcal disease, human papillomavirus, and varicella [s2]. Reporting on the change places RSV, hepatitis A, hepatitis B, dengue, and meningococcal ACWY and B in the high-risk category, and influenza, COVID-19, and rotavirus among those under shared clinical decision-making [s3].

The AAP's position is that the federal changes "depart from longstanding medical evidence and no longer offer the optimal way to prevent illnesses in children," and that its own recommendations are built on the specific disease risks and health care delivery arrangements of the United States [s1].

That last clause is the substantive disagreement, stated compactly. The federal assessment reasoned outward from an international comparison, finding the U.S. an outlier among 20 peer developed nations in the number of diseases covered and doses recommended [s2]. The Academy is reasoning inward from domestic epidemiology. Both are defensible framings; they do not produce the same schedule.

Why two schedules is not merely a disagreement

A childhood immunization schedule is not only clinical advice. It is a routing document. Insurance coverage rules, the Vaccines for Children program, state school entry requirements, electronic health record prompts, and pharmacy protocols are all built to reference a schedule, and historically they referenced one.

CDC states that all three of its categories require insurance companies to cover the listed vaccines without cost-sharing, and CMS Administrator Mehmet Oz said in the announcement that "no family will lose access" [s2]. What is not addressed in either the federal announcement or the AAP release is how the systems downstream resolve a case where the two schedules disagree — for example, a vaccine the Academy recommends routinely that the federal schedule assigns to a high-risk or shared-decision category.

A related uncertainty concerns liability. STAT reported on January 8 that the federal changes create new uncertainty about manufacturers' legal protections [s4]. The Vaccine Injury Compensation Program's architecture is tied to federal recommendations, and reclassification is not a neutral act within it.

What is not yet known

Whether states will follow the federal schedule, the AAP schedule, or neither in setting school requirements. How insurers and the Vaccines for Children program will treat vaccines that changed category. Whether clinicians practising under two schedules will document their reasoning differently. None of these have answers as of late January.

What can be said is narrower: as of January 26, a parent asking "what does the schedule say" has two authoritative answers, and they are not the same.

This article is informational and is not medical advice. Decisions about vaccination for an individual child belong with a clinician who knows that child's history.